Growth in Asian and South American markets boost sales for Danish
firm Chr Hansen, counterbalancing a fall in revenue in North
America for the first quarter of the year.
Denmark's Chr Hansen is considering breaking up into two separate
entities, one focused on food and pharmaceutical ingredients and
the other a pharmaceutical pure-play making allergy vaccines and
asthma treatments, activities...
The ingredients division of Danish company Chr Hansen pulled in a
DKK 369 million (€49m) profit for the fiscal year on sales of DKK
3.4 billion (€460m), a slight dip on the previous year on rising
costs.
Danish ingredients company Chr Hansen has ramped up its production
capacity in the US for its pharmaceutical products via a $10
million (€8.2m) expansion of its facilities in Stoughton in the US.